🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiumei Huang

Southern Medical University

ORCID: 0000-0002-7306-0288
Pharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyNursingMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer”.

Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.01575
N/A
0DataRank · unranked
20 citations

S. Louise Pay, Naveen Singh, I‐Ju Yeh, Snehal B. Bhandare, Xiaolin Su +5 more

NQO1-Bioactivatable Therapeutics as Radiosensitizers for Cancer Treatment

IntechOpen eBooks(2020)10.5772/intechopen.90205
N/A
0DataRank · unranked
1 citations

Edward A. Motea, Xiumei Huang, Colton L. Starcher, Jayne M. Silver, I‐Ju Yeh +6 more

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation

Frontiers in Oncology(2021)10.3389/fonc.2021.747282
N/A
0DataRank · unranked
24 citations

Lingxiang Jiang, Ting Fang, Fei Fang, Yingchun Liu, Ye Zhao +9 more

PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage

Cancer Letters(2021)10.1016/j.canlet.2021.07.040
N/A
0DataRank · unranked
18 citations

Jiangwei Wang, Lingxiang Jiang, Yaomin Chen, Tao Lu, Marc S. Mendonca +2 more

Neutrophils: Musketeers against immunotherapy

Frontiers in Oncology(2022)10.3389/fonc.2022.975981
N/A
0DataRank · unranked
31 citations

Umar Raza, Soumya Tumbath, Lingxiang Jiang, Wenjuan Xu, Xiumei Huang +1 more

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

Genes & Diseases(2022)10.1016/j.gendis.2022.04.001
N/A
0DataRank · unranked
16 citations

Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang +13 more

KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway

Frontiers in Oncology(2022)10.3389/fonc.2022.976292
N/A
0DataRank · unranked
6 citations

Yingchun Liu, Xiaolin Su, Jiangwei Wang, Ye Zhao, Soumya Tumbath +9 more

Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer

Cancers(2023)10.3390/cancers15194742
N/A
0DataRank · unranked
15 citations

Matthew Martin, Benlian Wang, Guanglong Jiang, Faranak Alipourgivi, Xiumei Huang +4 more

Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill NQO1 -Positive Pancreatic Cancer Cells

Antioxidants and Redox Signaling(2023)10.1089/ars.2022.0224
N/A
0DataRank · unranked
6 citations

Yingchun Liu, Soumya Tumbath, Matthew W. Boudreau, Lindsay E. Chatkewitz, Jiangwei Wang +8 more

STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity

Science Advances(2025)10.1126/sciadv.adx5495
N/A
0DataRank · unranked
4 citations

Naresh Singh, Chengxian Xu, Dehui Kong, Samantha Sharma, Sheng Liu +15 more

Forward genetics identifies HN1L/JPT2 as a novel carboplatin resistance gene in ovarian cancer

Genes & Diseases(2025)10.1016/j.gendis.2025.101720
N/A
0DataRank · unranked
0 citations

Aishat Motolani, Kenneth P. Nephew, Guanglong Jiang, Faranak Alipourgivi, Steven Sun +6 more